Eupraxia Pharmaceuticals ...

NASDAQ: EPRX · Real-Time Price · USD
5.32
0.04 (0.76%)
At close: Aug 15, 2025, 3:49 PM
5.30
-0.43%
After-hours: Aug 15, 2025, 04:55 PM EDT

Eupraxia Pharmaceuticals Income Statement

Financials in CAD. Fiscal year is undefined.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a
Cost of Revenue
209.91K 193.27K 111.53K
Gross Profit
-209.91K -193.27K -111.53K
Operating Income
-37.2M -22.63M -20.87M
Interest Income
407.04K 569.32K 65.73K
Pretax Income
-38.33M -23.92M -23.37M
Net Income
-37.39M -23.26M -22.99M
Selling & General & Admin
9.65M 5.65M 8.89M
Research & Development
27.54M 17.2M 9.68M
Other Expenses
0.00 -0.00 n/a
Operating Expenses
37.2M 23.2M 18.68M
Interest Expense
821.66K 1.59M 1.3M
Selling & Marketing Expenses
n/a n/a n/a
Cost & Expenses
37.2M 23.2M 18.68M
Income Tax Expense
48.26K 930.52K -1.34M
Shares Outstanding (Basic)
24.15M 19.29M 14.24M
Shares Outstanding (Diluted)
24.15M 19.29M 14.24M
EPS (Basic)
-1.58 -1.24 -1.61
EPS (Diluted)
-1.58 -1.24 -1.61
EBITDA
-36.75M -22.14M -21.96M
EBIT
-36.9M -22.33M -22.07M
Depreciation & Amortization
149.57K 193.27K 111.53K